Charles J. "Chuck" Fleischmann
Suspicious Timing Detected
5 flagsRep. Fleischmann sold $1,001 - $15,000 in $UNH on 2026-02-20 — 20 days before the PBM Kickback Prohibition Act (HR7895) was introduced, a bill that could negatively impact integrated health services.
Rep. Fleischmann sold $1,001 - $15,000 in $UNH on 2026-02-20 — 20 days before HR7902, a bill that would withdraw FDA approval for mifepristone and establish a federal tort for chemical abortion drug harm.
Rep. Fleischmann sold $1,001 - $15,000 in $PINS on 2026-02-20 — 24 days before the Children and Teens’ Online Privacy Protection Act (S836) moved to the House, a bill that could impact social media platforms.
Rep. Fleischmann sold $1,001 - $15,000 in $UNH on 2026-02-20 — 27 days before S.J. Res. 141, which would reinstate stricter medical debt collection regulations, potentially increasing costs for health-related entities.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Date |
|---|---|---|---|---|
| SELL | $ADBE | Adobe Sys Inc Com (ADBE) | $1K-$15K | Feb 20, 2026 |
| SELL | $EEFT | Euronet Worldwide Inc Com (EEFT) | $1K-$15K | Feb 20, 2026 |
| SELL | $PYPL | Paypal Hidgs Inc Com (PYPL) | $1K-$15K | Feb 20, 2026 |
| SELL | $PINS | Pinterest Inc CLA (PINS) | $1K-$15K | Feb 20, 2026 |
| SELL | $NOW | Servicenow Inc Com (NOW) | $1K-$15K | Feb 20, 2026 |
| SELL | $UNH | United Health Group Inc Com (UNH) | $1K-$15K | Feb 20, 2026 |
| SELL | $ACN | Accenture PLC Ireland SHS CL A (ACN) | $1K-$15K | Feb 23, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
A bill to establish standards and guidelines to make open Government data assets artificial intelligence-ready, and for other purposes.
S.4098 (AI-Ready Data Act) is an early-stage Senate bill that directs NIST to develop standards for making open government data AI-ready. No funding is authorized, and the bill sits in committee with only one cosponsor and two legislative actions since March 2026. Passage probability is low in its current form, limiting near-term market impact. Winners would be federal IT consultants and systems integrators like Accenture ($ACN) and IBM ($IBM) if momentum builds.
Living Donor Protection Act of 2025
The Living Donor Protection Act of 2025 (S.1552), reported favorably out of committee and on the Senate calendar, prohibits life, disability, and long-term care insurers from discriminating against living organ donors. This removes an underwriting barrier, expands the insured pool, and drives increased transplant volume. Major managed care and insurance stocks have rallied 9-39% in the last 30 days, with this legislation providing a structural tailwind for revenue growth across the sector.
Federal Loan Systems Modernization Act of 2026
HR 7789 (Federal Loan Systems Modernization Act) is an early-stage authorization bill with zero appropriations, no funding mechanism, and no near-term revenue impact for any company. The bill merely authorizes GSA to plan a centralized Lending.gov platform. Actual contract awards require separate appropriations legislation that does not exist. Market reaction is nonexistent.
Information Quality Assurance Act of 2025
HR6329 is an early-stage, pre-appropriation procedural bill requiring OMB to update federal data quality guidelines. It authorizes zero direct funding and creates a low-single-digit-million-dollar consulting opportunity for federal IT advisory firms. All four tracked tickers declined over the past 7 days, consistent with the bill's lack of material revenue catalyst. No near-term market impact.
Dental Care for Veterans Act
The Dental Care for Veterans Act (HR210) expands VA dental eligibility to all enrolled veterans, creating an estimated $5-10B annual procurement opportunity for dental suppliers. The bill has 95 cosponsors and passed committee hearings but no appropriations are authorized. HSIC and XRAY are the strongest structural beneficiaries given their pure-play dental exposure.
Main Street Capital Access Act
HR6955 (Main Street Capital Access Act) passed out of the House Financial Services Committee on 2026-04-20 and is now on the Union Calendar. This is the most significant banking deregulation bill of the 119th Congress. It reduces capital requirements, streamlines merger reviews, modernizes the discount window, and promotes de novo bank formation. Large banks, community banks, and fintech lenders all benefit structurally. Market has already priced in initial momentum with broad banking gains over the last 30 days.
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
HR 7902 (Safeguarding Women from Chemical Abortion Act) would withdraw FDA approval for mifepristone for pregnancy termination and create a federal tort for harm from chemical abortion drugs. The bill was introduced March 12, 2026, referred to two committees, and is in early legislative stages with only 6 cosponsors. Revenue exposure for $PFE and $TEVA is immaterial to their overall financials — less than 0.1% of revenue for each. The bill has effectively no near-term market impact.
PBM Kickback Prohibition Act
HR7895 is an early-stage House bill banning referral compensation to PBMs. It has no Senate companion, sits at the start of the legislative process, and has near-zero passage probability in this Congress. Market data shows the three largest PBM-associated stocks (CVS, UNH, CI) have rallied significantly over the past 30 days — this bill is not a driver of those moves. The bill's impact, if enacted, would be immaterial to all three companies' financials.
Children and Teens’ Online Privacy Protection Act
The Children and Teens' Online Privacy Protection Act (S836) passed the Senate unanimously and now awaits House action, expanding COPPA to cover teens up to age 16. This directly prohibits targeted advertising to teens without parental consent, structurally harming the ad-revenue models of major social platforms. The four largest pure-play and diversified ad platforms — META, GOOGL, SNAP, PINS — face a combined estimated annual revenue headwind of $430M to $1.72B from lost youth-targeted ad inventory.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
S.J. Res. 141 would reinstate stricter medical debt collection rules by disapproving the CFPB's 2025 withdrawal of its 2024 Regulation F rule. For hospital operators like EHC, UHS, and HCA, this increases bad debt expense and compliance costs. The resolution is on the Senate calendar but has not passed—the market impact is currently anticipatory, not realized. EHC has already declined 5.4% in the past two weeks on negative sentiment.
Other Filings by Charles J. "Chuck" Fleischmann
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.